Combinaton of radiation and hormone suppression therapy shown to effectively treat early-stage prostate cancer

Results similar to success in treating advanced-stage cancers

BOSTON -- In the first study of its kind, researchers at Brigham and Women's Hospital (BWH) and Dana-Farber Cancer Institute (DFCI) have found that combined radiation therapy (RT) and androgen suppression therapy (AST) is a more effective treatment for localized, early-stage prostate cancer compared to treatment using radiation therapy alone. The findings are published in the September 13th issue of JAMA (Journal of the American Medical Association).

"Previous studies have shown a benefit to treating advanced-stage prostate cancer with radiation and hormone therapy," said Anthony V. D'Amico, MD, PhD, of BWH and DFCI. "This is the first study to show that the combination treatment may also benefit people with early-stage cancer."

Prostate cancer is the second leading cause of cancer death among men in this country. The American Cancer Society estimates that about 184,500 American men will be diagnosed with the disease this year and 39,200 will die.

In the study, researchers compared the relative risk of prostate specific antigen (PSA) failure during a five-year period in men who underwent RT and AST as treatment for diagnosed early-stage prostate cancer compared with men who received RT.

Although no significant difference between treatment groups was found in patients in the low-risk category, men who were classified in the intermediate-risk group and received both therapies for their cancer were five times less likely to have PSA failure than men who received RT alone. For men in the high-risk group who received both RT and AST, the effectiveness of combination therapy was more profound; they were two and one-half times less likely to have PSA failure than men who had received RT. "While further research is needed, it appears that the one-two punch of RT and AST may be a more effective treatment in the battle against both advanced-stage and early-stage prostate can

Contact: Todd Ringler - DFCI
Dana-Farber Cancer Institute

Page: 1 2

Related medicine news :

1. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
2. Combining PET and CT scans leads to more accurate radiation therapy for lung cancer patients
3. NASA awards $9.8 million NSCOR grant to UT Southwestern to study effects of space radiation exposure
4. Florida Tech scientist wins patent for device to deliver X-ray irradiation
5. Adding radiation therapy to chemotherapy improves survival in patients with high-risk breast cancer
6. More precise radiation therapy lets prostate cancer patients avoid erectile dysfunction
7. Combining hormones with external, internal radiation helps high risk prostate cancer patients
8. Timing appears essential to combining antiangiogenesis and radiation therapy
9. Can the standard course of radiation therapy following lumpectomy be shortened?
10. Understanding how prostaglandin prevents gut injury during radiation therapy
11. Paclitaxel chemotherapy for breast cancer not associated with serious radiation pneumonitis

Post Your Comments:

(Date:7/17/2019)... ... July 16, 2019 , ... A medical home care program found that ... key to better care for seniors. While this may not sound surprising, a recent ... through its Brandman Research Institute (BRI) uncovered several surprising outcomes based on a simple ...
(Date:7/17/2019)... ... ... Dr. Jonathan Zaidan, MD, FACOG, President of Women’s Excellence discusses a new weight loss ... on Wednesday, July 17ths at 7pm. The show podcast will be available online ... the challenges that women face when it comes to weight loss and any health ...
(Date:7/13/2019)... ... July 13, 2019 , ... ZALO , the leading luxury sex toy ... and clitoral massager. To view the product and its accompanying video click here ... personal massagers to people around the world,” said Mara Epstein, director of sales. “The ...
(Date:7/13/2019)... DIEGO (PRWEB) , ... July 12, 2019 , ... ... today announced the launch of its proprietary patient management platform, Ospitek “View”. Ospitek ... surgery center executives to deliver a fully customizable, intelligent, solution made specifically for ...
(Date:7/13/2019)... ... July 12, 2019 , ... China Focus ... Center , sponsored by Hangzhou Investment Promotion Bureau, Fox Rothschild LLP, MORE Health ... The conference attracted Fosun Pharmaceuticals, WuXi Biologics, Kelun Pharmaceutical, Harbin Pharmaceuticals, Fountain Medical, ...
Breaking Medicine News(10 mins):
(Date:7/17/2019)... ... ... Women’s Excellence is pleased to offer Natural Family Planning (NFP) to women ... birth regulation that is consistent with Catholic marriage vows by which a couple recognizes ... from all sexual contact during the fertile time. To achieve pregnancy, the couple engages ...
(Date:7/13/2019)... ... July 12, 2019 , ... Dickinson Wright PLLC ... the critical business and legal issues facing the ever-changing health care industry. Recognizing ... group combining the experience of its health care and restructuring/bankruptcy attorneys who can ...
(Date:7/13/2019)... ... July 12, 2019 , ... ... communicate and socialize with others. Given how widespread autism is (approximately 1 in ... While autism cannot be “cured,” there are treatment options to teach children with ...
Breaking Medicine Technology:
Cached News: